Introduction
Innovative biomedical techniques for the therapy and support in a wide range of diseases (among others joint destruction, coronary, electrophysiological or valvular heart diseases) gained growing importance during the last decades [1] . Permanent or transient devices and implants bear the risk of bacterial colonisation and subsequent device-related infection leading to bacteraemia and sepsis. Numerous risk factors have been identified to be associated with device associated infections (DAI) and prevention of DAI is aimed at different targets ranging from clarifying the indication for treatment, handling procedures, or, innovative material applications. However, one of the most important complications, biomedical engineers, surgeon and other scientists are confronted with, is the formation of microbial biofilms on medical devices [2] , characterized by a strong adhesive power to the surface of medical devices and reduced antimicrobial susceptibility.
Methods
We reviewed the literature at the US National Library of Medicine -PubMed and the ScienceDirect databases to summarise current articles concerning device associated infection with special emphasis on blood stream infections. Search terms included "blood stream infection", "biofilm", "intravasal infection", "medical device", or "risk factor" and specific devices (for example "central venous catheter", "pacemaker stimulation electrodes", "cardiac valve" etc.). Abstracts of retrieved citations were reviewed and prioritized by relevant content.
Results and Discussion
Rates and risks of device-associated infections: Among the complications of implantable devices infections seem to have the greatest negative impact on patient outcome [2, 3] . In patients with endocarditis the proportion of patients with intra-cardiac devices rose from 13.3% to 18.9% between 1998 and 2009 in the US [4] . Central venous catheter (CVC) infections range from 0.2 to 4.2 episodes per 1000 CVC days [5, 6] . Apart from other non-cardiac (like IV-drug abuse, age, dental surgery) and cardiac factors (like valvular disorders or cardiomyopathy) CVC also play a role as risk factors for infective endocarditis.
Bacterial agents:
In device associated infections grampositive cocci, especially Staphylococcus aureus play a central role (Fig. 2) [7] . In a study with ventricular assist devices median time to infection was 68 days and Staphylococcus aureus was the most common pathogen (44.2%), followed by streptococci (38%), see Table 1 [8]. Prevention of device associated infections: Cardiac implantable electronic devices have been covered with an antibiotic impregnated envelope to prevent bacterial infection. A retrospective cohort study showed a reduction of device associated infection rates from 3% to 0.4% (p = 0.04) compared with non-impregnated devices after 90 days [9] . Other concepts include the use of antisense molecules, quorum-sensing inhibitors, or bacteriophages [10] .
Figure 2: Janeway lesions typical for Staphylococcus aureus endocarditis
In ventricular assist devices a new tunneling technique of the driveline into the fascia of the musculus rectus abdominis, achieved a reduction in ascending infections from 22.5% (n = 9) to 4.9% (n = 2, p < 0.001) [11] . The amount of handling of implantable venous access devices, among other risk factors (Table 3) , has been shown to increase contamination and catheter-related infection. Using prefilled syringes instead of manually filled syringes for flushing of venous catheters reduced the infection rate from 6.3% to 2.7% (p=0.016) in a retrospective cohort study [13] . Over all the strict selection of medical devices [14] and a reduction to the shortest possible time of use is one of the mainstays of prevention of device associated infections.
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